Xiaoyan Liu
机构：Shanghai University, Guangzhou University of Chinese Medicine, Minzu University of China, Qingdao Agricultural University, Shandong University, Shanxi Medical University, Capital Medical University, Xiamen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Wenzhou Medical University, Beijing Chao-Yang Hospital, Capital Medical University, First Affiliated Hospital of Wenzhou Medical University, China International Science and Technology Cooperation, First Affiliated Hospital of Xiamen University, First Affiliated Hospital of Guangzhou Medical University, Huadong Hospital, Institute of Oceanology, Capital Institute of Pediatrics, Jiangsu Provincial Center for Disease Control and Prevention, Wuhan Children's Hospital, Shenzhen Luohu People's Hospital, Jiangxi Provincial Children's Hospital, State Key Laboratory of Respiratory Disease, Qilu Hospital of Shandong University, Fu Wai Hospital, Chongqing Medical University, Guangzhou Medical University, Shanxi Normal University · ORCID：0000-0002-1732-5923
发表论文 974 篇 · 总被引 21659 次 · h-index 66
代表论文
- Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease (2026 · New England Journal of Medicine · 被引 6)
- Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China (2025 · Journal of Alzheimer s Disease · 被引 3)
- Multisystem Langerhans cell histiocytosis with hypothyroidism and sclerosing cholangitis: a case report and review of the literature (2026 · Journal of Medical Case Reports)
- Integrated Metagenomic and Metabolomic Profiling Identifies Severity-Specific Gut Microbiota Signatures Across A-B-E Phenotypes in Clinically Stable COPD: A Cross-Sectional Study (2026 · Microorganisms)
- Differential effects of primary and latent syphilis co-infection on immune reconstitution and virological failure in HIV-positive adults on ART (2026 · BMC Public Health)
- Gut mycobiota alteration contributes to the pathogenesis of Pneumocystis pneumonia (2026 · Figshare)